Heart rate variability in type 2 diabetes mellitus: A systematic review and meta-analysis.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
metabolic syndrome 3 endocrinologydiseases
obesity 3 endocrinologydiseases
type 2 diabetes mellitus 10 endocrinologydiseases
diabetes mellitus 11 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
diabetes mellitus 48 Title: PLoS ONEHeart rate variability in type 2 diabetes mellitus : A systematic review and meta–analysisAlternative Title: HRV in T2DMThomas Benichou (Investigation)
diabetes mellitus 4060 AvailabilityAll relevant data are within the paper and its Supporting Information files.IntroductionType 2 diabetes mellitus (T2DM) is a public health concern [[1]]. T2DM is increasingly frequent in the world in association with
diabetes mellitus 22405 showed similar results.10.1371/journal.pone.0195166.g002Fig 2Meta–analysis of RR intervals of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
diabetes mellitus 22713 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g003Fig 3Meta–analysis of SDNN of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
diabetes mellitus 23046 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g004Fig 4Meta–analysis of RMSSD of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
diabetes mellitus 23412 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g005Fig 5Meta–analysis of pNN50 of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
diabetes mellitus 23775 SD: Standard Deviation.10.1371/journal.pone.0195166.g006Fig 6Meta–analysis of total power of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
diabetes mellitus 24084 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g007Fig 7Meta–analysis of the LF of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
diabetes mellitus 24395 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g008Fig 8Meta–analysis of the HF of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
diabetes mellitus 24706 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g009Fig 9Meta–analysis of LF/HF of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
diabetes mellitus 26849 10).10.1371/journal.pone.0195166.g010Fig 10Meta–regression of factors influencing heart rate variability in type 2 diabetes mellitus .95% CI: 95% confident intervals; RR: RR intervals; SDNN: Standard Deviation of RR intervals; pNN50:
metabolic syndrome 4248 in the world in association with the increase of sedentary behaviours, unhealthy diet, obesity and metabolic syndrome [[2]–[6]]. The number of people with T2DM is predicted to double within the next three decades [[1]].
metabolic syndrome 14066 circadian autonomic rhythm in insulinoresistant subjects [[45]], in cases of bowel preparation [[63]], metabolic syndrome [[47]], circadian rhythm in relation to blood adiponectin [[62]], or dimethylarginine levels [[61]],
metabolic syndrome 28070 [[68]], schizophrenia [[69]], multiple sclerosis [[70]], active ulcerative colitis [[71]], obesity and metabolic syndrome [[72],[73]], myocardial infarctions [[74]], high blood pressure [[75]], smoking [[76]], and cancer [[77]],
obesity 4236 increasingly frequent in the world in association with the increase of sedentary behaviours, unhealthy diet, obesity and metabolic syndrome [[2]–[6]]. The number of people with T2DM is predicted to double within the
obesity 28058 depression [[68]], schizophrenia [[69]], multiple sclerosis [[70]], active ulcerative colitis [[71]], obesity and metabolic syndrome [[72],[73]], myocardial infarctions [[74]], high blood pressure [[75]], smoking
obesity 32442 relationships have been either found [[88],[89]] or not [[90],[91]] in the literature. However, the severity of obesity –related diseases is not directly linked to the accumulation of total body fat but rather to its distribution,
type 2 diabetes mellitus 41 Title: PLoS ONEHeart rate variability in type 2 diabetes mellitus : A systematic review and meta–analysisAlternative Title: HRV in T2DMThomas Benichou (Investigation)
type 2 diabetes mellitus 22398 and showed similar results.10.1371/journal.pone.0195166.g002Fig 2Meta–analysis of RR intervals of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
type 2 diabetes mellitus 22706 Diabetes Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g003Fig 3Meta–analysis of SDNN of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
type 2 diabetes mellitus 23039 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g004Fig 4Meta–analysis of RMSSD of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
type 2 diabetes mellitus 23405 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g005Fig 5Meta–analysis of pNN50 of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
type 2 diabetes mellitus 23768 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g006Fig 6Meta–analysis of total power of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
type 2 diabetes mellitus 24077 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g007Fig 7Meta–analysis of the LF of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
type 2 diabetes mellitus 24388 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g008Fig 8Meta–analysis of the HF of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
type 2 diabetes mellitus 24699 Mellitus; SD: Standard Deviation.10.1371/journal.pone.0195166.g009Fig 9Meta–analysis of LF/HF of type 2 diabetes mellitus patients compared with controls.-: non reported data (missing SD were also non reported). 95% CI: 95%
type 2 diabetes mellitus 26842 10).10.1371/journal.pone.0195166.g010Fig 10Meta–regression of factors influencing heart rate variability in type 2 diabetes mellitus .95% CI: 95% confident intervals; RR: RR intervals; SDNN: Standard Deviation of RR intervals; pNN50:

You must be authorized to submit a review.